Evidence map›Paper›PMID 25225458›Full record

ArticleThe Journal of experimental medicine2014

Dysfunctional CD8+ T cells in hepatitis B and C are characterized by a lack of antigen-specific T-bet induction.

Peter D Kurktschiev, Bijan Raziorrouh, Winfried Schraut, Markus Backmund, Martin Wächtler, Clemens-Martin Wendtner, Bertram Bengsch, Robert Thimme, Gerald Denk, Reinhart Zachoval and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 107 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. T cell adaptation in chronic infections and tumors.Cellular & molecular immunology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Marine life science & technology · 2024
    Article
  10. Article
  11. Article
  12. Hepatitis C virus modified sE2Journal of virology · 2024
    Article
  13. Review
  14. Development of a CD8Heliyon · 2023
    Article
  15. Review
  16. Advances in Immunotherapy for Hepatitis B.Pathogens (Basel, Switzerland) · 2022
    Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 2 countries.

Peter D KurktschievInstitute for Immunology, Ludwig-Maximilians-University, 80539 Munich, Germany Department of Medicine II, University Hospital Munich, 80539 Munich, Germany peter.kurktschiev@med.uni-muenchen.de.
Bijan RaziorrouhInstitute for Immunology, Ludwig-Maximilians-University, 80539 Munich, Germany Department of Medicine II, University Hospital Munich, 80539 Munich, Germany.
Winfried SchrautInstitute for Immunology, Ludwig-Maximilians-University, 80539 Munich, Germany Department of Medicine II, University Hospital Munich, 80539 Munich, Germany.
Markus BackmundDepartment of Medicine II, University Hospital Munich, 80539 Munich, Germany PiT - Praxis im Tal, 80331 Munich, Germany.
Martin WächtlerDepartment of Medicine, Klinikum Schwabing, 81925 Munich, Germany.
Clemens-Martin WendtnerDepartment of Medicine, Klinikum Schwabing, 81925 Munich, Germany.
Bertram BengschDepartment of Medicine II, University Hospital Freiburg, 79106 Freiburg, Germany.
Robert ThimmeDepartment of Medicine II, University Hospital Freiburg, 79106 Freiburg, Germany.
Gerald DenkDepartment of Medicine II, University Hospital Munich, 80539 Munich, Germany.
Reinhart ZachovalDepartment of Medicine II, University Hospital Munich, 80539 Munich, Germany.
Andrea DickLaboratory of Immunogenetics and Molecular Diagnostics, 80539 Munich, Germany.
Michael SpannaglLaboratory of Immunogenetics and Molecular Diagnostics, 80539 Munich, Germany.
Jürgen HaasDivision of Infection and Pathway Medicine, University of Edinburgh, Edinburgh EH16 4SB, Scotland, UK.
Helmut M DiepolderDepartment of Medicine II, University Hospital Munich, 80539 Munich, Germany.
Maria-Christina JungLeberzentrum München, 80336 Munich, Germany.
Norbert H GruenerInstitute for Immunology, Ludwig-Maximilians-University, 80539 Munich, Germany Department of Medicine II, University Hospital Munich, 80539 Munich, Germany.
München Klinik · DELudwig-Maximilians-Universität München · DEImmungenetics (Germany) · DEMünchen Klinik Schwabing · DEUniversity Medical Center Freiburg · DEOrthopädische Praxis · DEUniversity of Edinburgh · GB

Funding

Medical Research Council G0501453
6 · The paper itself

Abstract

The transcription factor T-bet regulates the production of interferon-γ and cytotoxic molecules in effector CD8 T cells, and its expression correlates with improved control of chronic viral infections. However, the role of T-bet in infections with differential outcome remains poorly defined. Here, we report that high expression of T-bet in virus-specific CD8 T cells during acute hepatitis B virus (HBV) and hepatitis C virus (HCV) infection was associated with spontaneous resolution, whereas T-bet deficiency was more characteristic of chronic evolving infection. T-bet strongly correlated with interferon-γ production and proliferation of virus-specific CD8 T cells, and its induction by antigen and IL-2 stimulation partially restored functionality in previously dysfunctional T-bet-deficient CD8 T cells. However, restoration of a strong interferon-γ response required additional stimulation with IL-12, which selectively induced the phosphorylation of STAT4 in T-bet(+) CD8 T cells. The observation that T-bet expression rendered CD8 T cells responsive to IL-12 suggests a stepwise mechanism of T cell activation in which T-bet facilitates the recruitment of additional transcription factors in the presence of key cytokines. These findings support a critical role of T-bet for viral clearance and suggest T-bet deficiency as an important mechanism behind chronic infection.

Indexed as

CD8-Positive T-LymphocytesFlow CytometryHepatitis BHepatitis CHumansInterferon-gammaInterleukin-12PhosphorylationSTAT4 Transcription FactorStatistics, NonparametricT-bet Transcription FactorT-Box Domain ProteinsInterferon-gammaInterleukin-12STAT4 protein, humanSTAT4 Transcription FactorT-bet Transcription FactorT-Box Domain Proteins

Identifiers

PMID25225458
PMCPMC4172217
OpenAlexW2167827953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.